October 2024 – Page 5

Icon, Irish CRO Giant, Announces Layoffs Following Disappointing Q3 Performance

6 months ago talkbio0Tagged CRO, Icon brand of cyhalothrin, Industry, Irish (ethnic group), Performance

Icon, layoffs, Q3 performance, Irish CRO, biotech industry

Mitigating Risks in mRNA Manufacturing: Strategies for Smooth Transition from Preclinical to Clinical Stages

6 months ago talkbio0Tagged analytical method, Automation, bony process, clinical transition, Control Groups, Materials, Preclinical, Quality, regulatory, Risk Management, RNA, Messenger

mRNA manufacturing, risk management, preclinical to clinical transition, quality control, regulatory compliance, raw material selection, process automation, analytical methods.

Revolution Medicines Advances in Pancreatic Cancer Treatment with RMC-6236 and RMC-9805

6 months ago talkbio0Tagged cellular targeting, Clinical Trials, inhibitors, Pancreatic carcinoma, ras Oncogene, Revolution Medicines, RMC-6236, RMC-9805

Revolution Medicines, RMC-6236, RMC-9805, pancreatic cancer, RAS inhibitors, targeted therapies, clinical trials

Revolutionizing AATD Treatment: Emerging Therapies to Replace Augmentation Therapy

6 months ago talkbio0Tagged alpha 1-Antitrypsin Deficiency, Alpha-1, Antitrypsin Deficiency, augmentation therapy, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, Hereditary Diseases, RNA Interference

Alpha-1 Antitrypsin Deficiency (AATD), Genetic Disorder, New Therapies, Augmentation Therapy, RNA Interference (RNAi), Gene Editing, CRISPR

GSK’s Arexvy RSV Vaccine Shows Promise in Younger Adults, Following Pfizer’s Approval

6 months ago talkbio0Tagged Abrysvo, Arexvy, Pfizer, Respiratory syncytial virus, Respiratory Tract Diseases, SmithKline Beecham, Vaccines, younger adults

GSK, Arexvy, RSV vaccine, younger adults, Pfizer, ABRYSVO, respiratory syncytial virus, lower respiratory tract disease

GSK Invests $800 Million in Pennsylvania Site Expansion to Boost Vaccine and Medicine Production

6 months ago talkbio0Tagged expansion, Investments, Manufacturing, Pennsylvania, production, SmithKline Beecham, Vaccines

GSK, Pennsylvania, manufacturing expansion, vaccine production, medicine manufacturing, $800 million investment

Lyell Immunopharma Acquires ImmPACT Bio to Bolster CAR T-cell Therapy Pipeline

6 months ago talkbio0Tagged Autoimmune Diseases, Automobiles, Bio, Biotechnology, Cancer Therapeutic Procedure, Lyell Immunopharma, pipeline acquisition, T-cell therapy

Lyell Immunopharma, ImmPACT Bio, CAR T-cell therapy, pipeline acquisition, biotechnology, cancer treatment, autoimmune diseases

Iterum Therapeutics Secures FDA Approval for Orlynvah, Breaking Two-Decade Drought in New UTI Treatments

6 months ago talkbio0Tagged Approved, Etzadroxil, Iterum, Oral cavity, Orlynvah, Penem, probenecid, Uncomplicated, United States Food and Drug Administration, Urinary tract infection, uUTIs

Iterum Therapeutics, FDA Approval, Orlynvah, Uncomplicated Urinary Tract Infections (uUTIs), Sulopenem Etzadroxil and Probenecid, Oral Penem

Gilead Withdraws US Indication for Sacituzumab Govitecan in Metastatic Urothelial Cancer

6 months ago talkbio0Tagged Accelerated, Approved, Govitecan, Malignant neoplasm of urinary bladder, sacituzumab, Trodelvy, United States Food and Drug Administration, urothelial cancer, Withdraw (activity)

Sacituzumab Govitecan, Trodelvy, Bladder Cancer, Urothelial Cancer, Gilead Sciences, FDA, Accelerated Approval Withdrawal

Medtronic’s Affera System: A Breakthrough in Electrophysiology with FDA Approval for All-in-One Pulsed Field Ablation

6 months ago talkbio0Tagged Affera, Approved, Atrial Fibrillation, Cardiac ablation, Electrophysiology (science), field ablation, Medtronic, United States Food and Drug Administration

Medtronic, Affera, FDA approval, pulsed field ablation, electrophysiology, atrial fibrillation, cardiac ablation